In vivo decontamination of the nerve agent VX using the domestic swine model

References

• Greenfield RA, Brown BR, Hutchins JB, Iandolo JJ, Jackson R, Slater LN, Bronze MS. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 2002; 323: 326–340.
   PubMed Web of Science ®Google Scholar
• Hamilton MG, Hill I, Conley J, Sawyer TW, Caneva DC, Lundy PM. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination. Mil Med 2004; 169:856–862.
   PubMed Web of Science ®Google Scholar
• Munro NB, Ambrose KR, Watson AP. Toxicity of the organophosphate chemical warfare agents GA, GB and VX: implications for public protection. Environ Health Persp 1994; 102:18–38.
   PubMed Web of Science ®Google Scholar
• Sidell FR. Nerve agents. In: Zajtchuk R, Bellamy RF, eds. Textbook of military medicine: medical aspects of chemical and biological warfare. Washington, DC: Office of the surgeon General, Department of the Army, 1997:129–179.
   Google Scholar
• Chilcott RP, Jenner J, Carrick W, Hotchkiss SAM, Rice P. Human skin absorption of Bis-2-(chloroethyl)sulphide (sulphur mustard) in vitro. J Appl Toxicol 2000; 20:349–355.
   PubMed Web of Science ®Google Scholar
• Chilcott RP, Jenner J, Hotchkiss SAM, Rice P. In vitro skin absorption and decontamination of sulphur mustard: comparison of human and pig-ear skin. J Appl Toxicol 2001; 21:279–283.
   PubMed Web of Science ®Google Scholar
• Chilcott RP, Jenner J, Hotchkiss SAM, Rice P. Evaluation of barrier creams against sulphur mustard: (I) In vitro studies using human skin. Skin Pharmacol Appl Skin Physiol 2002; 15:225–235.
   PubMedGoogle Scholar
• Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig. Basic Clin Pharmacol Toxicol 2005; 97:35–38.
   PubMed Web of Science ®Google Scholar
• Millerioux J, Cruz C, Bazire A, Polly V, Lallement G, Lefeuvre L, Josse D. Evaluation of in vitro tests to assess the efficacy of formulations as topical skin protectants against organophosphorus compounds. Toxicol in Vitro 2009; 23:127–133.
   PubMed Web of Science ®Google Scholar
• Munro NB, Watson AP, Ambrose KR, Griffin GD. Treating exposure to chemical warfare agents: implications for health care providers and community emergency planning. Environ Health Perspect 1990; 89:205–215.
   PubMed Web of Science ®Google Scholar
• Hauschild VD, Watson A, Bock R. Decontamination and management of human remains following incidents of hazardous chemical release. Am J Disaster Med 2012; 7:5–29.
   PubMedGoogle Scholar
• Chilcott RP. 2011. CBRN Contamination. In: Harrison RM, Nichols GL, Maynard RL, eds. Environmental Medicine Ayres. London: Hodder Arnold, 2011:475–486.
   Google Scholar
• Macintyre AG, Christopher GW, Eitzen E, Gum R, Weir S, DeAtley C, . Weapons of mass destruction events with contaminated casualties: effective planning for health care facilities. J Am Med Assoc 2000; 283:242–249.
   PubMed Web of Science ®Google Scholar
• Braue EH Jr., Smith KH, Doxzon BF, Lumpkin HL, Clarkson ED. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX. Cutan Ocul Toxicol 2011; 30:15–28.
   PubMed Web of Science ®Google Scholar
• Braue EH, Smith KH, Doxzon BF, Lumpkin HL, Clarkson ED. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, Part 2: Guinea pigs challenged with soman. Cutan Ocul Toxicol 2011; 30: 29–37.
   PubMed Web of Science ®Google Scholar
• Bjarnason S, Mikler J, Hill I, Tenn C, Garrett M, Caddy N, Sawyer TW. Comparison of selected skin decontaminant products and regimens against VX in domestic swine. Hum Exp Toxicol 2008; 27:253–261.
   PubMed Web of Science ®Google Scholar
• Yang YC, Baker JA, Ward JR. Decontamination of chemical warfare agents. Chem Rev 1992; 92:1729–1743.
   Web of Science ®Google Scholar
• Cabal J, Kassa J, Severa J. A comparison of the decontamination efficacy of foam-making blends based on cationic and nonionic tensides against organophosphorus compounds determined in vitro and in vivo. Hum Exp Toxicol 2003; 22:507–514.
   PubMed Web of Science ®Google Scholar
• Kallol KG, Shuchi T, Marek J, Kuca K. New insights into detoxification of chemical warfare simulants and pesticides using micelle mediated systems. Main Group Chem 2010; 9:337–353.
   Web of Science ®Google Scholar
• Amlot R, Larner J, Matar H, Jones DR, Carter H, Turner, EA. Comparative analysis of showering protocols for mass-casualty decontamination. Prehos Disaster Med 2010; 25:435–439.
   PubMed Web of Science ®Google Scholar
• Chilcott RP. An overview of the Health Protection Agency's research and development programme on decontamination. Chemical Hazards and Poisons report 2009; 15:26–28.
   Google Scholar
• Josse CF, Bui-Tho J, Denisan C, Cruz C, Bifarella R, Amlot R, Chilcott RP. Comparison of showering protocols effectiveness for human volunteers’ skin decontamination. Toxicol Lett 2011; 205:204.
   Google Scholar
• Misik J, Pavlikova R, Josse D, Cabal J, Kuca K. In vitro skin permeation and decontamination of the organophosphorus pesticide paraoxon under various physical conditions - evidence for a wash-in effect. Toxicol Mech Methods 2012; 22: 520–525.
   PubMed Web of Science ®Google Scholar
• Duncan EJS, Conley JD, Grychowski KD, Conley SA, Lundy PM, Hamilton MG, Sawyer TW. A comparison of the effects of sarin and succinylcholine on respiratory parameters in anesthetized domestic swine. Mil Med 2001; 166:322–327.
   PubMed Web of Science ®Google Scholar
• Dorandeu F, Mikler JR, Thiermann H, Tenn C, Davidson C, Sawyer TW, . Swine models in the design of more effective medical countermeasures against organophosphorus poisoning. Toxicology 2007; 233:128–144.
   PubMed Web of Science ®Google Scholar
• Simon GA, Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations–an overview. Skin Pharmacol Appl Skin Physiol 2000; 13:229–234.
   PubMedGoogle Scholar
• Wester RC, Noonan PK. Relevance of animal-models for percutaneous absorption. Int J Pharm 1980; 7:99–110.
   Web of Science ®Google Scholar
• Dorandeu F, Foquin A, Briot R, Delacour C, Denis J, Alonso A, . An unexpected plasma cholinesterase activity rebound after chalenge with a high dose of the nerve agent VX. Toxicology 2008; 248: 151–157.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney DK, Andres V, Featherstone RM. A new and rapid collorymetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7:88–95.
   PubMed Web of Science ®Google Scholar
• Brain KR, Chilcott RP. Physicochemical factors affecting skin absorption. In: Chilcott RP, Price S, eds. Principles and practice of skin toxicology. Chichester: John Wiley and Sons, 2008:83–92.
   Google Scholar
• Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Hamilton MG. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig. Hum Exp Toxicol 2003; 22:255–261.
   PubMed Web of Science ®Google Scholar
• Duncan EJS, Brown A, Lundy P, Sawyer TW, Hamilton M, Hill I, Conley JD. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine. J Appl Toxicol 2002; 22:141–148.
   PubMed Web of Science ®Google Scholar
• Ferry LL, Argentieri G, Lochner DH. The comparative histology of porcine and guinea pig skin with respect to iontophoretic drug delivery. Pharm Acta Helv 1995; 70:43–56.
   PubMedGoogle Scholar
• Maxwell DM, Brecht KM, Koplovitz I, Sweeney RE. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?Arch Toxicol 2006; 80:756–760.
   PubMed Web of Science ®Google Scholar
• Sawyer TW, Mikler J, Worek F, Reiter G, Thiermann H, Tenn C, . The therapeutic use of localized cooling in the treatment of VX poisoning. Toxicol Lett 2011; 204, 52–56.
   PubMed Web of Science ®Google Scholar
• Karasova JZ, Bajgar J, Jun D, Pavlikova R, Kuca K. Time-course changes of acetylcholinesterase activity in blood and some tissues in rats after intoxication by Russian VX. Neurotox Res 2009; 16, 356–360.
   PubMed Web of Science ®Google Scholar
• Wachtel TL, McCahan GR. The contractile response of the spleen of miniature swine to intra-arterial infusion of epinephrine. Lab Anim Sci 1974; 24:329–334.
   PubMedGoogle Scholar
• Jimmerson VR, Shih TM, Mailman RB. Variability in soman toxicity in the rat: correlation with biochemical and behavioural measures. Toxicology 1989; 57:241–254.
   PubMed Web of Science ®Google Scholar
• Lotti M. Cholinesterase inhibition: Complexities in interpretation. Clin Chem 1995; 41:1814–1818.
   PubMed Web of Science ®Google Scholar